FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

Go back to FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
(NASDAQ: FOCL) Delayed: 6.09 +0.21 (3.57%)
Previous Close $5.88    52 Week High
Open $5.96    52 Week Low
Day High $6.18    P/E N/A 
Day Low $5.76    EPS
Volume 92,554